Luminex Corporation Revenue per Employee (LMNX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Luminex Corporation  (NASDAQ: LMNX)
 

Luminex's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 22.41% in the first quarter 2021, year on year to cumulative value of $438 million, Luminex's revenue per employee grew on a trailing twelve months basis to $ 380,574. The productivity of Luminex's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 109 other companies have achieved higher revenue per employee. While Luminex's total ranking has deteriorated compared to the previous quarter from 0 to 1347. Luminex has 1,150 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LMNX Revenue per Employee (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter
Y / Y Revenue Change 22.41 % 23.08 % 34.81 % 31.86 % 9.73 %
Sales per Employee (TTM) $ 380,574 362,953 344,786 320,971 297,960
LMNX's Total Ranking # 1347 # 0 # 0 # #
Seq. Revenue Change -0.63 % 5.03 % -3.16 % 21.12 % -0.09 %

LMNX Company Profile >> Back to LMNX Efficiency Comparisons >> Compare LMNX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 17
Healthcare Sector # 110
Overall Market # 1347

Revenue per Employee Statistics
High Average Low
$ 397,266 $ 252,257 $ 185,585
(Mar 31 2021)   (Dec 31 2013)



Financial Statements
Luminex's Revenue MRQ $ 111 Millions Visit LMNX's Income Statement
Luminex's Revenues TTM $ 438 Millions Visit LMNX's aggregate revenue growth
What are LMNX's Sales? Visit LMNX's Sales by Segment




Other Ratios
Luminex's Income per Employee
Employees in Medical Equipment & Supplies
Medical Equipment & Supplies Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
LMNX's Revenue per Employee versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for LMNX's Competitors
Revenue per Employee for LMNX's Suppliers
Revenue per Employee for LMNX's Customers

You may also want to know
LMNX's Sales Growth Rates LMNX's Pe Price to earnings ratio LMNX's Receivables Turnover Ratio LMNX's Stock Quote
LMNX's Net Income Growth Rates LMNX's Ps Price to Sales ratio LMNX's Sales per Employee LMNX's Asset Turnover Ratio
LMNX's Net Margin LMNX's Pb Price to Book ratio LMNX's Financial Strength Ratios LMNX's Dividend Payout Ratio
Date modified: 2026-08-29T17:28:10+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2021, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2021Number of Employees Mar 31 2021
Adamas Pharmaceuticals Inc  660,758.33 $ 79.291  Million 120 
Catalyst Pharmaceuticals Inc   660,117.20 $ 120.141  Million 182 
Healthlynked Corp  658,087.40 $ 6.581  Million 10 
Emmaus Life Sciences Inc   652,969.70 $ 21.548  Million 33 
Reshape Lifesciences Inc  651,722.22 $ 11.731  Million 18 
Heron Therapeutics Inc   650,437.50 $ 83.256  Million 128 
Merck and Co Inc   640,226.67 $ 48,017.000  Million 75,000 
Phenomex Inc   606,605.26 $ 69.153  Million 114 
Retractable Technologies Inc  600,666.47 $ 120.734  Million 201 
Johnson and Johnson  598,110.80 $ 84,214.000  Million 140,800 
Spero Therapeutics Inc   597,160.00 $ 14.929  Million 25 
Regeneron Pharmaceuticals Inc   596,859.18 $ 9,197.600  Million 15,410 
Cerus Corporation  596,434.03 $ 171.773  Million 288 
Pfizer Inc  592,813.33 $ 44,461.000  Million 75,000 
Korro Bio Inc   592,603.45 $ 34.371  Million 58 
Perrigo Company Plc  584,234.57 $ 4,732.300  Million 8,100 
Moderna Inc   581,277.87 $ 2,732.006  Million 4,700 
Fulgent Genetics Inc   575,437.50 $ 773.388  Million 1,344 
Acadia Pharmaceuticals Inc   574,236.84 $ 458.241  Million 798 
Luna Innovations Inc  573,993.75 $ 91.839  Million 160 
Biomarin Pharmaceutical Inc  572,622.17 $ 1,844.416  Million 3,221 
Fortress Biotech Inc   567,538.46 $ 44.268  Million 78 
3m Company  544,793.39 $ 32,960.000  Million 60,500 
Eargo Inc   541,606.90 $ 78.533  Million 145 
Pacira Biosciences inc   534,366.71 $ 442.990  Million 829 
Masimo Corp  533,255.45 $ 1,173.162  Million 2,200 
Neurocrine Biosciences Inc   522,700.00 $ 1,045.400  Million 2,000 
Amicus Therapeutics inc   522,041.10 $ 266.763  Million 511 
Yunhong Green Cti Ltd   515,792.98 $ 26.821  Million 52 
Kaya Holdings Inc   515,625.00 $ 1.031  Million 2 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.